课题基金 / 基金详情

Studies on Generation of Human-human Hybridomas and Optimization of Antibody Production

Studies on Generation of Human-human Hybridomas and Optimization of Antibody Production
人-人杂交瘤的产生和抗体生产优化的研究
批准号:
62560089
负责人:
YAMADA Koji
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988

项目摘要

项目成果

YAMADA Koji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Human-human hybridomas producing monoclonal antibodies (MoAb) specific to human breast cancer cells were isolated and used then for detection of human breast cancer specific antigens. One of MoAb reacted specifically with about 40 k dalton antigens in human breast cancer McF-7 cells.2. We screened widely immunoglobulin production stimulating factor (IPSF) and found that culture super natants or lysates of human lung adenocarcinoma PC-8, human lymphoblastoid HO-323 and namalwa cells had IPSF activity. The IPSF activity was also found in lactoferrin, skim milk and its main component casain, chick egg yolk lipoprotein (YLP), and phosphate salts. These IPSFs except YLP stimulated IgM production of human-human and mouse-mouse hybridomas, but did not IgG production of IgG producers. YLP solely stimulated both IgM and IgG production of hybridomas. These results suggest that IgM production of hydridomas is regulated diffevently with IgG production3. Serum-free high-density culture of human-human hybridomas was studied for mass production of humon monoclonal antibodies. Hybridomas derived from NAT-30, a human parent cells isolated from Namalwa cells, proliferated well in serum-free medium up to 10^7 cells/ml and Ig productivity of the hybridomas at the high cell density was even higher than those at lower cell densities. Onthe contrary, hybridomas derived from HO-323 cells, another hunan parent cells, lost viability and IG productivity guickly at the high cell density. These results suggest that applicability to serum-free high-density culture is varies with hybridomas.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
S.Sato: Cytotechnology.
S.Sato:细胞技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Aihara: "Production of Human-human Hybridomas Secreting Monoclonal Antibodies Reactive to Breast Cancer Cell Lines" In Vitro Cell. Develop. Biol.24. 295-300 (1988)
K. Aihara:“在体外细胞中生产分泌对乳腺癌细胞系有反应的单克隆抗体的人-人杂交瘤”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Aihara: In Vitro Cell.Develop.Biol.24. 959-962 (1988)
K.Aihara:体外细胞.Develop.Biol.24。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Shinmoto.: Cytotechnology. 1. 295-300 (1988)
H.Shinmoto.:细胞技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Development of a surgical simulator for high difficulty hepatobiliary endoscopic surgery
    • 批准号:
      19K09150
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2019
    • 负责人:
      YAMADA Koji
    • 依托单位:
    Search for tubulin regulatory molecules and elucidate the site of active expression for the creation of novel anticancer drugs
    • 批准号:
      18K06718
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      YAMADA Koji
    • 依托单位:
    The Development of an Idealized Trocar Layout Decision System for Laparoscopic Surgery for Neurologically Impaired Children Based on Abdominal Working Space Calculations Made Using a 3D Scanner
    • 批准号:
      16K11350
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2016
    • 负责人:
      YAMADA Koji
    • 依托单位:
    Search for tubulin regulatory molecules derived from marine invertebrates aimed at the development of novel anticancer agents
    • 批准号:
      26460124
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2014
    • 负责人:
      YAMADA Koji
    • 依托单位:
    海外基金